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Abstract.
Neurally Adjusted Ventilatory Assist (NAVA) is a mode of ventilation that is triggered by
neither flow nor pressure but by the electrical activity of the diaphragm (Stein & Firestone, 2018,
p. 227). NAVA puts ventilatory control into the hands of the patient and is often used in neonates
who are more challenging to ventilate. Medical practitioners, however, are skeptical to put this
mode of ventilation into practice with fear that neonates are neither strong enough nor capable to
manage their own respiratory efforts without hypoventilation or damage to the lungs (Lubarsky
et al., 2020, p. 3). Research shows that despite these apprehensions, neonates are able manage
their own breathing safely and effectively (Lubarsky et al., 2020; Stein & Firestone, 2018).
NAVA also offers some benefits in comparison to other traditional modes of ventilation such as
quicker weaning, better patient-ventilator synchrony, and decreased work of breathing (Stein &
Firestone, 2018, p. 228, 232; Matlock et al., 2020; Schmidt et al., 2012). The NAVA technology
does not simply stop at ventilation alone; it is an additional asset that can provide CPAP with
backup ventilation in cases of Apnea of Prematurity and can aid in detecting CCHS, a
hypoventilation syndrome (Hussain et al., 2020; Rauf et al., 2019). NAVA is of great value to the
neonatal intensive care unit and beyond.
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Introduction.
Mechanical ventilation is used in patients when they are unable to control and maintain
their respiratory efforts. This is to ensure a patient receives adequate oxygenation and ventilation
delivery while they recover from the predisposing issue causing their failure to be able to breathe
completely on their own (Verbrugghe & Jorens, 2011, p. 328). Within mechanical ventilation,
there are several different modes of ventilation such as Volume Control, Pressure Control,
Pressure Regulated Volume Control, etcetera. Each of these modes of ventilation delivers a
breath uniquely and is used for different circumstances, but gets the job done nonetheless. All
assisted modes of mechanical ventilation can be triggered by the patient spontaneously when
they want a breath. This means the ventilator delivers a breath when it senses an inspiratory
effort by either flow or pressure. A flow-triggered mode will deliver a breath when the patient
inhales a certain amount of flow which is measured in liters per minute, while a
pressure-triggered mode will deliver a breath when a drop in pressure is detected within the
circuit (p. 328). Then, there is a new mode of ventilation called Neurally Adjusted Ventilatory
Assist (NAVA). NAVA is triggered by neither flow nor pressure, but by the electrical signal of
the diaphragm (Stein & Firestone, 2018, p. 227).
The electrical signal from the diaphragm is referred to as Edi and is detected by a
specialized nasogastric tube which is placed at the level of the diaphragm in the patient (Stein &
Firestone, 2018, p. 227). The diaphragm contracts by demand of the central nervous system and
the phrenic nerve in order to initiate a breath, so to have inspiratory effort detection at the level
of the diaphragm is of benefit (Verbrugghe & Jorens, 2011, p. 329). Once the ventilator senses
the electrical impulse from the diaphragm, the machine will deliver an amount of flow that is
proportional to the amount of electrical activity that was sensed (Stein & Firestone, 2018, p.
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227). NAVA puts much of the control of ventilation into the hands of the patient and allows for
several advantages to be seen through this newer mode of ventilation and patient triggering.
NAVA is used in neonates and pediatric patients primarily because they are much more
difficult to effectively ventilate due to asynchrony, air leaking around the endotracheal tube used
to deliver breaths, their higher respiratory rates, and because children often are not as sedated as
an adult patient would be (Firestone, K., personal communication, November 25, 2020).
Additionally, other modes of ventilation triggered by flow or pressure are harder to be precise in
neonates due to their tiny nature; a pressure or flow difference in a neonate is minuscule
compared to that of an adult. NAVA is still rather new to the healthcare field as its debut occurred
only eleven years ago, and there are many health care practitioners who already have all the
means to do so, but do not implement this new mode of ventilation in their NICUs and PICUs.
Many are apprehensive to allow a neonate or a pediatric patient to have so much control over
their own breathing (Lubarsky et al., 2020, p. 3). However, there is adequate evidence to
convince a neonatologist who already has the equipment, to implement NAVA in their NICUs
and PICUs.
In order to implement NAVA, the hospital must already have, or be willing to purchase
the necessary equipment and software. The Neurally Adjusted Ventilatory Assist mode is only
offered on the Getinge-Maquet Servo ventilators but can be delivered both invasively and
noninvasively (Verbrugghe & Jorens, 2011, p. 331). Invasive deliverance is through the
endotracheal tube, while noninvasive deliverance could be through a mask or a RAM cannula
similar to normal noninvasive ventilation (p. 333). The only other additional item the medical
practitioner needs to deliver NAVA would be the special nasogastric tube to be able to place at
the level of the diaphragm and detect the Edi (p. 331).
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Research.
Some doctors and healthcare professionals are skeptical to believe that a neonate can
control their own respiratory efforts. This means that they are afraid that the neonate may take
too large of breaths causing barotrauma due to the large amount of pressure delivered to their
tiny lungs (Lubarsky et al., 2020, p. 3). Another worry is that they will take too few, tiny breaths
leading to inadequate ventilation and oxygenation (p. 3). However, ample evidence is present to
prove that a neonate can indeed tell us what is best for them.
A study on the changes of the electrical activity of the diaphragm in response to painful
stimuli was conducted to seek and answer these very concerns. Because NAVA “delivers
inspiratory pressure in proportion to the electrical activity of the diaphragm, and because NAVA
allows self-regulation of [peak inspiratory pressure], there is apprehension that painful stimulus
may increase respiratory drive and result in excessive [peak inspiratory pressure]” (Lubarsky et
al., 2020, p. 3). This study was conducted on fourteen neonates less than 32 weeks of age on
NAVA and NIV NAVA, and the painful stimulus was a heel stick which was already ordered for
a necessary blood sample on the patient (p. 3). The results of this study proved that “although
premature neonates respond to pain with increases in their respiratory drive, these increases do
not trigger sustained, excessive PIPs” (Lubarsky et al., 2020, p. 8). This study adds to the
literature in proving that while there may be a slight increase for the neonate’s respiratory drive
momentarily, it is still within normal limits. It is imperative that the healthcare professionals
simply set appropriate limits so that the staff is aware when more dangerous pressures are being
reached.
An additional built-in safeguard to prevent the over ventilation and increased pressures
worried upon by healthcare professionals would be that of the Hering-Breur reflex. The
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Hering-Breuer reflex is a lung protective mechanism evident in both neonates and adults. It
works “as the lung inflation progresses, vagally mediated stretch receptors in the lungs sense an
adequate level of lung distension and turn off inspiration, so the ventilator will be cycled off
when neural exhalation begins” (Stein & Firestone, 2018, p. 228). This lung protective strategy
may be an explanation to the results seen in research conducted by changing the NAVA levels in
premature neonates to see its effect on the peak inspiratory pressure. This was done by increasing
the NAVA level by 0.5 cm H 2O μV-1 every 3 minutes, starting at 0.5 and ending at 4.0 cm H2O
μV-1 (Firestone et al., 2015, p. 1). The outcome of this study revealed that as the NAVA level was
initially increased, the peak inspiratory pressures and amount of respiratory support also
increased. However, as the NAVA level continued to rise, a breakpoint (BrP) was reached (p. 3).
This breakpoint is where the PIP seemed to plateau based on a safe level delivered to the
neonate, which suggested that an adequate amount of ventilatory support was reached without
over distending the lungs. As the NAVA level passed the breakpoint, the pressure did not
increase further; simply more muscle unloading was present, which gave most of the control to
the ventilator rather than the patient (p. 3). This study adds to the evidence that even as the
NAVA level is increased, neonates still have the reflective responses to signal when enough
pressure has been delivered to their lungs to protect from over-distention.
Benefits.
Neurally adjusted ventilatory assist has also proved to provide better patient-ventilator
synchrony. A study done to compare NIV NAVA versus NAVA concluded that NIV NAVA
“produces marked improvement in patient-ventilator synchrony compared with NIV” (Matlock
et al., 2020, p. 952). This study was conducted with fifteen subjects who were randomly placed
on NIV NAVA or NIV and monitored using respiratory inductance plethysmography, then
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switched to the other method and monitored once more (p. 950). The study concluded that NAVA
decreased patient-ventilator asynchrony, but their methods did not seem to find conclusive
results for a decreased work of breathing (WOB) which seems to be apparent in different
literature (p. 950).
This decrease in work of breathing is something that is continually being studied after a
study on piglet lungs concluded a true decrease in work of breathing in NIV NAVA mode (Jones
et al., 2015, p. 1478). Twelve healthy neonatal piglets were randomly started on either regular
NIV or NIV NAVA and then measured later on the alternate mode. The piglet was then measured
in both modes with injured lungs, which was mimicked by a saline solution washout. The lungs
were considered injured when their compliance was 50-70% of the baseline (p. 1480). The work
of breathing was measured based on pressure waveforms for the pressure-time-product (PTP) (p.
1481). The first pressure-time-product was the area of the pressure curve with respect to time
from the initiation of the breath to the beginning of the ventilator pressurization, and this
represented the patient’s work of breathing required to trigger a breath (p. 1481). The results
showed a significant difference in the PTP work of breathing area under the curve between NIV
NAVA and regular NIV (p. 1482). It proved that work of breathing was decreased in both healthy
and unhealthy lungs in NIV NAVA compared to NIV. This is likely because NIV NAVA allows
the patient to control their own breathing efforts and take an additional sigh breath when
necessary, which would increase recruitment within the lungs and increase lung compliance (p.
1483). It is likely that similar findings have not been found in neonates because of the lack of a
control group, which the piglet study had. The piglet study was able to view the work of
breathing both before and after lung injury on NAVA, which simply is not doable in a neonate
study.
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NAVA can also be of benefit to patients post-cardiac surgery because of the lower
average airway pressures. As intrathoracic pressures increase with positive pressure ventilation,
this reduces the venous return of the heart and the afterload of the right ventricle (Crulli et al.,
2018, p. 208). In patients post-cardiac surgery, it is imperative to minimize the ventilatory
pressure (p. 208). Research was conducted for this reason to see if the pressures delivered by
way of NAVA were less than the pressures delivered by conventional ventilation and if NAVA
was of beneficial use in post-cardiac surgery patients (p. 208). This study used NAVA in 33 of
their cardiac surgery patients, and compared the pressures to the other 525 patients who were
ventilated conventionally post-cardiac surgery (p. 210). The overall results showed that not only
were the average peak inspiratory pressures lower in NAVA mode, the average airway resistance
was also reduced (p. 211). And while this research lacks a control group, the research is still
beneficial in addressing the use of NAVA in post-cardiac surgical patients. An additional use of
NAVA in this particular research was during weaning, and its success was seen in 71% of their
patients without the need for reintubation (p. 210). This information is of value once again to add
to the knowledge that NAVA can be used to facilitate spontaneous breathing much quicker to aid
in sooner extubation.
An added bonus to the NAVA technology is that it allows the neonate to strengthen
naturally and wean themselves from the support. While in the NAVA mode, the neonate is able to
strengthen their main respiratory muscle, the diaphragm. As their lung compliance increases,
meaning their lungs are able to stretch and expand and work better, their respiratory drive and
demand will decrease, which is proportional to the Edi detected by the catheter (Stein &
Firestone, 2018, p. 232). As the Edi decreases, the peak inspiratory pressures and tidal volumes
delivered by the ventilator will also decrease (p. 232). This means that the neonate is
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progressively doing their own work while the ventilator is still there to assist if necessary. (Stein
& Firestone, 2018, p. 232).
Additional Uses.
The NAVA technology does not stop being useful when it comes to invasive and
noninvasive ventilation in neonates. There are additional uses that are also of benefit to the
purchasing hospital and the health care practitioners involved in implementing the technology.
The first of these benefits still lies within the pediatric field but is even more useful than for
ventilation alone. There is new research being conducted to use NAVA on a level of zero for
CPAP. Apnea of Prematurity is a common condition in neonates where they become apneic, or
stop breathing for more than 20 seconds (Hussain et al., 2020). If a neonate were placed on a
NAVA with a level of zero, this simply means that they would be receiving simple positive
pressure ventilation without any additional support just like if they received bubble CPAP or
something similar. The advantage with this is that if the neonate does slip into apnea, and the
ventilator set up with NAVA senses that there is no Edi signal, it will automatically switch into
backup ventilation. This is beneficial to ensure that the patient is constantly and adequately
receiving appropriate ventilation and oxygenation rather than simply hoping the neonate will be
just fine. The neonate will be placed on NAVA level zero so that they can try to become strong
and breathe sufficiently on their own until outside intervention is absolutely necessary. This
NAVA level of zero as CPAP “may offer a safe and effective option to avoid non-invasive
ventilation or intubation due to premature neonates failing CPAP due to frequent CSEs from
[Apnea of Prematurity]” (Hussain et al., 2020; Firestone et al., 2020).
This alternative to prolong or avoid intubation altogether is tremendous in the respiratory
field. Studies have continuously proven that once mechanical ventilation is initiated, mortality,
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morbidity, and infection rates increase. This is because “endotracheal intubation bypasses the
natural upper and lower respiratory tract defense mechanisms, increasing the risk of lung
invasion by harmful microorganisms'' (Weber, 2016, p. 178). Intubation, prolonged ventilation,
and ventilatory acquired pneumonias are costly to both the hospital and the families, avoiding
them altogether is beneficial. It is because of these intubation hazards that prolonged mechanical
ventilation is also something that should be avoided if possible and why removal of the tube as
soon as possible is preferred.
A case of NAVA being used to supplementally diagnose congenital central
hypoventilation syndrome (CCHS) has also been reported. CCHS is “a disease characterized by
shallow breathing during sleep due to negligible ventilatory sensitivity to hypercarbia and
hypoxemia” (Rauf et al., 2019, p. 536). The diagnosis of this syndrome is often determined by a
genetic test for PHOX2B mutation, which is not always easily available. However, NAVA has
been used to suspect this in order to begin the process to seek the proper testing (p. 536). This
happened when a patient had episodes of apnea at three and four months of life, brought to the
hospital, placed on the ventilator, and went apneic in CPAP. The patient was then placed on
NAVA to monitor the neural respiratory drive using the Edi. NAVA showed that Edi was virtually
absent during sleep which meant that respiratory drive was poor during sleep. After a normal
nerve conduction velocity test of the phrenic nerve ruled out neuropathy as a cause of the poor
Edi signal, proper testing to confirm the presence of CCHS was then conducted (p. 537). NAVA
was able to be used in this scenario to monitor the electrical activity of the diaphragm in
correspondence with the breathing pattern in order to help determine the cause of the apneas.

NEURALLY ADJUSTED VENTILATORY ASSIST:

11

Future Areas of Study.
More research needs to be conducted to determine the long-term effects of ventilating a
neonate in the NAVA mode of ventilation. It is not known if NAVA actually causes additional
pulmonary trauma, however, it is predicted that this is not the case due to the smaller peak
pressures delivered in the NAVA mode. This hypothesis is one that needs to be researched and
perhaps to find out if there are actually a decreased amount of chronic lung diseases post NAVA
ventilation. It is also not known how NAVA may affect certain disease processes long term.
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